Crestor 20mg(Rosuvastatin 20mg), Micardis 80mg(Telmisartan 80mg) , FDC
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Dyslipidemia & Hypertension
Conditions
Dyslipidemia & Hypertension
Trial Timeline
Jul 1, 2013 → Sep 1, 2013
NCT ID
NCT01975961About Crestor 20mg(Rosuvastatin 20mg), Micardis 80mg(Telmisartan 80mg) , FDC
Crestor 20mg(Rosuvastatin 20mg), Micardis 80mg(Telmisartan 80mg) , FDC is a phase 1 stage product being developed by Yuhan for Dyslipidemia & Hypertension. The current trial status is completed. This product is registered under clinical trial identifier NCT01975961. Target conditions include Dyslipidemia & Hypertension.
What happened to similar drugs?
15 of 20 similar drugs in Dyslipidemia & Hypertension were approved
Approved (15) Terminated (3) Active (3)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01975961 | Phase 1 | Completed |
Competing Products
20 competing products in Dyslipidemia & Hypertension